Introduction
Methods
Identification of reviews
-
Claimed to be “systematic reviews”
-
Aimed to identify all available health status measurement instruments in a particular population, as stated by the author
-
Concern health status measurement instruments that have been applied in an evaluative situation, i.e., instruments aimed to measure changes in health status over time in a longitudinal study
-
Aimed to report on or evaluate the measurement properties of the measurement instruments
Data extraction
Descriptive information on reviews
Appraisal of the review process
Description of the assessment of the methodological quality of primary studies
Description of the evaluation of the results of primary studies
Description of synthesizing the methodological quality and the results
Results
Identification of reviews
Reference | Population | Health status concept | Year of publication | PROa
| Proxyb
| Non-PROc
| Number of instr.d
|
---|---|---|---|---|---|---|---|
General health perception
| |||||||
Pickard [17] | Childhood acute lymphoblastic leukemia (ALL) | HR-QoL (health-related quality of life) | 2004 | Yes | Yes | Yes | 20 |
Eiser [51] | Children | QoL (quality of life) | 2001 | Yes | Yes | No | 43 |
Pal [52] | Children | Health status | 1996 | Yes | Yes | Yes | 9 |
Schmidt [53] | Children and adolescents | HR-QoL | 2002 | Yes | Yes | No | 16 |
Davis [54] | Children (0–12 years) | HR-QoL and QoL | 2006 | Yes | Yes | Yes | 38 |
Hunter [55] | Children and adolescents | Mental health | 1996 | Yes | Yes | Yes | 19 |
Brouwer [56] | Children with otitis media (0–18 years) | HR-QoL | 2005 | No | Yes | Yes | 15 |
Haywood [57] | People aged 60 years and over | HR-QoL | 2005 | Yes | Yes | No | 18 |
Haywood [39] | Older people aged 60 years and over | HR-QoL | 2005 | Yes | Yes | No | 15 |
Haywood [58] | Older people | HR-QoL | 2006 | Yes | Yes | No | 45 |
Hollifield [59] | Refugees | Health status (mental and physical), trauma, quality of care, and diagnostic | 2002 | Yes | No | No | 12 |
Haywood [60] | Ankylosing spondylitis (AS) | Health or HR-QoL | 2005 | Yes | No | No | 15 |
Namjoshi [61] | Bipolar disorder | HR-QoL | 2001 | Yes | No | No | 14 |
Michalak [62] | Bipolar disorder | HR-QoL | 2005 | Yes | No | No | 8 |
Okamoto [63] | Breast cancer | QoL | 2003 | Yes | No | No | 11 |
Edwards [64] | Caregivers of patients with cancer | QoL | 2002 | Yes | No | No | 4 |
Ringash [65] | Head and neck cancer | Disease-specific HR-QoL | 2001 | Yes | No | No | 11 |
Van Korlaar [66] | Chronic venous disease | QoL | 2003 | Yes | No | No | 16 |
Neelakantan [35] | Women with chronic pelvic pain | HR-QoL | 2004 | Yes | No | No | 30 |
Riemsma [67] | Cognitive impairment due to acquired brain injury | General health status | 2001 | Yes | Yes | No | 34 |
Jones [68] | Common chronic, benign gynecologic conditions | HR-QoL | 2002 | Yes | No | No | 14 |
Ettema [69] | Dementia | QoL | 2005 | Yes | Yes | Yes | 17 |
Salek [31] | Dementia/Alzheimer’s | QoL | 1998 | Yes | Yes | No | 9 |
Walker [32] | Dementia/Alzheimer’s | QoL | 1998 | Yes | Yes | Yes | 19 |
De Tiedra [70] | Dermatology | HR-QoL | 1998 | Yes | No | No | 23 |
Garratt [71] | Diabetes mellitus (type 1 and 2) | Disease-specific HR-QoL | 2002 | Yes | No | No | 9 |
Luscombe [72] | Diabetes mellitus type 2 | HR-QoL | 2000 | Yes | No | No | 31 |
Cagney [73] | End-stage renal disease (ESRD) | QoL | 2000 | Yes | No | No | 53 |
Edgell [74] | End-stage renal disease (ESRD) patients | HR-QoL | 1996 | Yes | No | Yes | 16 |
Kline [75] | Epilepsy and antiepileptic drug (AED) treatment | Condition specific HR-QoL | 1998 | Yes | No | No | 4 |
Leone [76] | Epilepsy (adults) | HR-QoL | 2005 | Yes | No | No | 45 |
Szende [77] | Hemophilia | HR-QoL and health status | 2003 | Yes | No | No | 19 |
De Kleijn [78] | Hemophilia (age >16 years) | Health status: body structure, body function, activities | 2002 | Yes | No | Yes | 34 |
De Boer [27] | HIV infected | HR-QoL | 1995 | Yes | No | No | 12 |
Clayson [79] | HIV/AIDS | HR-QoL | 2006 | Yes | No | No | 34 |
Bonomi [80] | Acute, chronic, and cancer pain | QoL, utility instruments | 2000 | Yes | No | No | 18 |
Symonds [81] | Incontinency | HR-QoL | 2003 | Yes | No | No | 10 |
Pallis [82] | Inflammatory bowel disease (IBD) | HR-QoL | 2000 | Yes | No | ? | 12 |
Cummins [83] | Intellectual disability | QoL | 1997 | Yes | No | No | 13 |
Garratt [84] | Knee problems | Health and QoL | 2004 | Yes | No | No | 16 |
Zanoli [85] | Lumbar disorders | HR-QoL | 2000 | Yes | No | No | 92 |
Clark [86] | Menorrhagia | QoL | 2002 | Yes | No | No | 30 |
Van Nieuwen-huizen [87] | Mental illness (severe) | QoL | 1997 | Yes | Yes | Yes | 11 |
Lehman [88] | Mental illnesses (severe and persistent) | QoL | 1996 | Yes | No | No | 10 |
Gruenewald [24] | Multiple sclerosis (severe) | HR-QoL | 2004 | Yes | Yes | No | 23 |
Marinus [89] | Parkinson’s disease | QoL | 2002 | Yes | No | No | 4 |
Heffernan [90] | Three degenerative neurological conditions: multiple sclerosis (MS), Parkinson’s disease, and motor neuron disease (MND) | Disease-specific health status | 2005 | Yes | No | No | 16 |
Jørstad [91] | Population over 50 years who had not suffered a stroke or Parkinson’s disease, or had undergone a lower limb amputation | Fall-related psychological outcome measures | 2005 | Yes | No | ? | 26 |
Rannard [92] | Primary biliary cirrhosis (PBC) | HR-QoL | 2004 | Yes | No | Yes | 20 |
De Korte [93] | Psoriasis | QoL | 2002 | Yes | No | No | 6 |
Lewis [94] | Psoriasis | HR-QoL | 2005 | Yes | No | No | 14 |
Hallin [95] | Spinal cord injury (SCI) | QoL | 2000 | Yes | No | No | 14 |
Matza [96] | Stress urinary incontinence or overactive bladder (OAB) | Condition-specific HR-QoL | 2004 | Yes | No | ? | 16 |
Golomb [46] | Stroke | HR-QoL including functioning and well-being | 2001 | Yes | No | No | 32 |
Buck [97] | Stroke | QoL | 2000 | Yes | No | No | 25 |
Drake [26] | Total knee arthroplasty (TKA) | Global patient rating scales | 1994 | No | No | Yes | 34 |
Prasad [98] | Working adults | Health-related work outcomes | 2004 | Yes | No | No | 12 |
Lofland [99] | Various | Health-related loss in work productivity | 2004 | Yes | No | No | 11 |
De Boer [34] | Vision impairments | Vision-related QoL | 2004 | Yes | No | No | 31 |
Lundström [100] | Sight-threatening eye disease | HR-QoL/vision-related QoL | 2006 | Yes | No | No | 16 |
Tripop [101] | Glaucoma | HR-QoL | 2005 | Yes | No | No | 10 |
Franic [102] | Voice disorders | QoL | 2005 | Yes | No | No | 9 |
Morley [103] | Chronic rhinosinusitis (patients undergoing endoscopic sinus surgery for) | HR-QoL | 2006 | Yes | No | No | 20 |
Watt [104] | Benign thyroid disorders | HR-QoL | 2006 | Yes | No | No | 6 |
Functional status (physical and psychosocial)
| |||||||
Ketelaar [105] | Children with cerebral palsy | Disability | 1998 | No | No | Yes | 17 |
Boyce [106] | Children with cerebral palsy | Motor performance or quality of movement | 1991 | No | No | Yes | 10 |
Buffart [107] | Children with congenital (unilateral) transverse or longitudinal reduction deficiencies of the upper limb | Arm/hand functioning | 2006 | Yes | Yes | Yes | 23 |
Pakulis [108] | Adolescent sarcoma patients (bone tumor) | Physical functioning | 2005 | Yes | No | Yes | 7 |
Moore [109] | English-speaking adult population | Functional living skills | 2006 | No | No | Yes | 31 |
Arrington [21] | Chronic medical or general populations | Sexual function | 2004 | Yes | No | No | 57 |
MacKnight [110] | Community-dwelling elderly | Performance-based mobility | 1995 | No | No | Yes | 41 |
Wind [111] | Healthy and disabled subjects | Functional capacity | 2005 | Yes | No | Yes | 27 |
Ramaker [25] | Parkinson’s disease | Impairment and disability | 2002 | No | No | Yes | 11 |
Mannerkorpi [112] | Fibromyalgia syndrome (FMS) | Functional limitations and disability | 1997 | Yes | No | Yes | 15 |
Grotle [28] | Low back pain | Functional status and disability | 2004 | Yes | No | No | 36 |
Millard [113] | Chronic pain | Pain-related disability | 1997 | Yes | No | No | 35 |
Dowrick [114] | Musculoskeletal disorders of the upper extremity/orthopaedic trauma population (e.g., fracture or dislocation) | Functional outcomes | 2005 | Yes | No | Yes | 7 |
Law [29] | Occupational therapy | Functional ability in activities of daily living (ADL) | 1989 | Yes | No | Yes | 13 |
Terwee [19] | Osteoarthritis of the hip or knee | Physical function | 2006 | No | No | Yes | 26 |
Dziedzic [115] | Osteoarthritis of the hand | Hand disability/functional disability | 2005 | Yes | No | No | 5 |
Swinkels [116] | Rheumatic disorders | Personal care disabilities | 2005 | Yes | No | No | 19 |
Swinkels [117] | Patients with rheumatic disorders | Impairments in functions | 2005 | Yes | No | Yes | 49 |
Swinkels [118] | Rheumatic disorders | Impairment | 2005 | Yes | No | Yes | 42 |
Swinkels [119] | Rheumatoid arthritis | Disabilities in gait and gait-related activities | 2004 | Yes | No | No | 61 |
McKibbin [120] | Seriously mentally ill, schizophrenia | Functioning | 2004 | No | No | Yes | 8 |
Keskula [121] | Shoulder conditions (athletes) | Functional limitations and disability | 2001 | Yes | No | Yes | 9 |
Michener [122] | Shoulder dysfunction | Functional limitations and disability | 2001 | Yes | No | No | 11 |
Bot [41] | Shoulder or shoulder-upper limb problems | Shoulder disability | 2004 | Yes | No | No | 16 |
Salerno [123] | Disorders of the neck and upper extremity (mild to moderate) | Functional status | 2002 | Yes | No | No | 13 |
Chong [124] | Stroke | Instrumental activities of daily living (IADL) | 1995 | Yes | No | Yes | 4 |
Croarkin [125] | Stroke | Upper extremity motor function tests | 2004 | No | No | Yes | 9 |
McGee [126] | Cardiac rehabilitation | Psychological outcome: depression, anxiety, and other negative affective states | 1999 | Yes | No | ? | 13 |
Sakzewski [127] | Children with cerebral palsy (5–13 years) | Participation | 2007 | Yes | Yes | Yes | 7 |
Morris [128] | Children with cerebral palsy (5–15 years) | Activity performance and participation as defined by ICF | 2005 | Yes | Yes | No | 7 |
Eadie [129] | Speech-language pathology | Communicative (functioning) participation | 2006 | Yes | No | No | 6 |
Symptoms
| |||||||
Brooks [130] | Adolescents | (Diagnose or measure) anxiety symptoms | 2003 | Yes | Yes | Yes | 9 |
Duhn [131] | Infants | Pain assessment | 2004 | No | Yes | Yes | 35 |
Ramelet [132] | Children (0–3 years) | Pain | 2004 | No | ? | Yes | 28 |
Stinson [133] | Children and adolescents | Pain | 2006 | Yes | No | No | 7 |
Eccleston [134] | Adolescents (11–18 years) | (Impact of) pain | 2005 | Yes | Yes | No | 43 |
Birken [135] | Preschool children (0–6 years) | Clinical asthma severity | 2004 | No | No | Yes | 10 |
Linder [136] | Children with cancer (0–18 years) | Physical symptoms | 2005 | Yes | Yes | Yes | 23 |
Stover [137] | Children less than 6 years old | PTSD symptoms and diagnostic measures | 2005 | Yes | Yes | Yes | 7 |
Devine [138] | Adults | Sleep dysfunction | 2005 | Yes | No | Yes | 22 |
Kirkova [139] | Adult cancer patients | Cancer symptoms | 2006 | Yes | Yes | Yes | 21 |
Vadaparampil [140] | Adults with hereditary breast, ovarian, and colon cancer | Psychological factors (depression, anxiety or distress) | 2005 | Yes | No | No | 11 |
Van Herk [141] | Older adults with severe cognitive impairments or communication difficulties | Pain | 2007 | No | No | Yes | 13 |
Stolee [142] | Cognitively impaired older persons | Pain | 2005 | Yes | No | Yes | 30 |
Zwakhalen [143] | Elderly people with dementia | Pain | 2006 | No | No | Yes | 12 |
Herr [144] | Nonverbal older adults with dementia | Pain | 2006 | No | No | Yes | 10 |
Smith [18] | Nonverbal older adults with advanced dementia | Pain | 2005 | No | Yes | Yes | 7 |
Schofield [145] | Adults with cognitive impairment | Pain | 2005 | Yes | Yes | Yes | 9 |
Schuurmans [146] | Delirium | Delirium (symptom severity) | 2003 | Yes | No | Yes | 8 |
Stanghellini [22] | Gastro-oesophageal reflux disease (GERD) | Symptom scales | 2004 | Yes | No | Yes | 20 |
Fraser [147] | Gastro-oesophageal reflux disease (GERD) or dyspepsia | Frequency or severity of GERD or dyspepsia symptoms | 2005 | Yes | No | No | 26 |
Bouchard [148] | Panic, panic disorders, agoraphobia | Aspects of panic attacks or panic disorder | 1997 | Yes | No | No | 14 |
Dorman [36] | Patients in palliative care | Breathlessness | 2007 | Yes | ? | ? | 29 |
Bausewein [149] | Chronic conditions such as OPD, cancer, chronic heart failure, and motor neuron disease | Breathlessness | 2007 | Yes | No | Yes | 33 |
Dittner [150] | Various | Fatigue | 2004 | Yes | No | ? | 30 |
Mota [151] | Adults | Fatigue | 2006 | Yes | No | No | 18 |
Biological and physiological processes
| |||||||
Van der Windt [20] | Preschool children (0–5 years) | Clinical scores for acute asthma | 1994 | No | No | Yes | 8 |
Moreau [152] | Low back pain | Isometric back extension endurance | 2001 | No | No | Yes | 6 |
Charman [153] | Atopic eczema | Disease-specific objective skin examination scales (severity) | 2000 | No | No | Yes | 13 |
Sun [154] | Osteoarthritis of hip and knee joints | Clinical rating systems | 1997 | Yes | No | Yes | 45 |
Innes [155] | General population/occupational therapy | Grip strength | 1999 | No | No | Yes | 13 |
Kettler [156] | People with cervical and lumbar disc and facet joint degeneration | Grading systems | 2006 | No | No | Yes | 42 |
Hudson [157] | Systemic sclerosis | Disease activity in systemic sclerosis | 2007 | No | No | Yes | 3 |
Combination
| |||||||
Daker-White [33] | General population | Sexual function, satisfaction or quality of life | 2002 | Yes | No | No | 23 |
Cremeens [158] | Children (3–8 years) | QoL, self-esteem, self-concept, and mental health measures | 2006 | Yes | No | No | 53 |
Hayes [159] | Critical care survivors | Impairment, functional status, and HR-QoL outcome measures | 2000 | Yes | No | Yes | 36 |
Pietronbon [160] | Various | Neck pain or dysfunction | 2002 | Yes | No | No | 5 |
Linder [161] | Acute sinusitis | HR-QoL and symptom scores | 2003 | Yes | No | No | 21 |
Hearn [162] | Cancer (advanced) | Outcome measures | 1997 | Yes | Yes | Yes | 12 |
Eechaute [42] | Chronic ankle instability | Patient-assessed instruments | 2007 | Yes | No | No | 3 |
Dorey [38] | Erectile dysfunction | Outcome measure | 2002 | Yes | Yes | Yes | 26 |
Veenhof [30] | Hip and/or knee OA | Pain, physical function, and patient global assessment | 2006 | Yes | No | No | 32 |
Razvi [163] | Hypothyroidism (adult) | Symptoms, health status, and QoL | 2005 | Yes | No | Yes | 9 |
Bijkerk [164] | Inflammatory bowel syndrome (IBS) | HR-QoL or symptoms | 2003 | Yes | No | ? | 10 |
Haywood [165] | Lateral ligament injury of the ankle | Multi-item measures of health outcome | 2004 | Yes | No | Yes | 9 |
Costa [43] | Low back pain | Outcome measures | 2007 | Yes | No | No | 15 |
Poolsup [166] | Mania | Global rating scales and symptom rating scales | 1999 | Yes | No | Yes | 13 |
Platz [23] | Spasticity | Clinical phenomena, function (ability to perform an activity independently) | 2005 | Yes | No | Yes | 37 |
D’Olhaberria-gue [167] | Stroke | Neurological examination; deficit or handicap and disability | 1996 | No | No | Yes | 14 |
Van Tuijl [40] | Tetraplegics | Upper extremity tests: strength tests, functional tests, and ADL tests | 2002 | Yes | No | Yes | 24 |
Margolis [168] | Visually impairments | Vision-specific HR-QOL or functioning or impact | 2002 | Yes | No | No | 22 |
Ashcroft [169] | Psoriasis | Clinical outcome measures to evaluate severity of psoriasis and its response to treatment | 1999 | Yes | No | Yes | 7 |
Avery [37] | Urinary and anal incontinence and vaginal and pelvic problems | QoL and symptoms | 2007 | Yes | No | No | 23 |
Bialocerkowski [170] | Wrist complaints | Wrist outcome instruments, performance or function | 2000 | Yes | No | Yes | 32 |
Appraisal of the review process
Search strategy described | |
Yes | 84% |
No | 16% |
Number of databases used | |
1 | 22% |
2 | 20% |
3 | 16% |
4 | 17% |
>4 | 24% |
Unclear | 2% |
Databases used | |
PubMed | 93% |
PsycINFO | 40% |
CINAHL | 39% |
EMBASE | 35% |
Cochrane library | 16% |
Selection of articles performed by at least two reviewers | |
Yes | 22% |
No | 3% |
Unclear | 75% |
Data extraction performed by at least two reviewers | |
Yes | 25% |
No | 4% |
Unclear | 71% |
Inclusion and exclusion criteria of primary studies described | |
Yes | 72% |
No | 28% |
Description of the assessment of the methodological quality of the primary studies and evaluation of the results
Internal consistency
| |
Standardsa (23×b) | Criteria of adequacyc (45×) |
Cronbach’s alpha (18×) KR-20 (2×), kappa (1×) Cronbach’s alpha is calculated for either the whole scale or for subscales depending on the outcome of the factor analysis (5×) Rasch analysis (2×) Rating system not specified (2×) | Alpha > 0.70 (26×) Alpha < 0.90 (9×), or not too high (1×) Alpha > 0.80 (3×) Alpha > 0.95 (2×) Range (e.g., 0.00–0.39 low; 0.40–0.59 moderate; 0.60–0.79 moderately high; 0.80–1.0 high, or alpha < 0.70 questionable; 0.71–0.80 moderate; >0.80 good) (10×) Distinction between cut-off score for group level and clinical use (2×) Rating system not specified (2×) |
Reliability
| |
Standards (29×) | Criteria of adequacy (57×) |
ICC: (18×) Kappa (10×) Correlation coefficient (e.g., Pearson’s or Spearman) (11×) Correlation not adequate (3×) Time interval mentioned (3×) Other measures, e.g., MDC, CV, Kendall’s tau, t-test, Goodman-Kruskall gamma, odds ratio, percentage agreement (7×) Rating system not specified (7×) | ICC > 0.70 (19×) ICC between 0.70 and 0.90 (7×) ICC > 0.50 (1×), >0.60 (2×), >0.75 (2×), >0.80 (3×), >0.90 (7×) Lower limit ICC > 0.60 (1×) Range ICC, kappa or r (18×) Distinction between, e.g., test-retest reliability and interrater reliability or discriminative versus evaluative use (3×) Minimum sample size (3×) Rating system not specified (13×) Example: Test-retest reliability: ICC < 0.6; ±ICC 0.6–0.8; +ICC > 0.8; Interobserver reliability: ICC < 0.5; ±ICC 0.5–0.7; +ICC > 0.7. |
Measurement error
| |
Standards (6×) | Criteria of adequacy (4×) |
Bland & Altman 95% LoA (5×) SEM (5×) Kappa (3×) MDC (1×) SDD/SDC (2×) | Rating system not specified (3×) LoA or SDC < M(C)IC (1×) |
Validity
| |
Standards (6×) | Criteria of adequacy (13×) |
Rating system not specified (3×) | Rating system not specified (12×) Correlation between 0.4 and 0.8 (1×) |
Content validity
| |
Standards and/or criteria of adequacy (21×) | |
Involvement of patients (7×) Judgement by reviewer (3×) Involvement of experts (4×) Examining the literature (2×) Statistical procedure (e.g., impact method, principal component analysis) (4×) Rating system not specified (3×) | |
Construct validity
| |
Standards (26×) | Criteria of adequacy (28×) |
Confirming hypotheses (11×) Calculation of correlation (8×) Distinction between different forms of validity (e.g., convergent validity, divergent validity, known group validity) (6×) Rating system not specified (3×) | Range (e.g., Cohen’s criteria or other, e.g., 0–0.39, 0.4–0.59, 0.6–0.79, 0.8–1.0) (11×) Hypotheses confirmed (7×) One cut-off point (e.g., r ≥ 0.40, or specified for, e.g., convergent validity, discriminant validity, known groups validity) (5×) Rating system not specified (3×) Other (e.g., number of populations validated) (2×) |
Criterion validity
| |
Standards (4×) | Criteria of adequacy (8×) |
Correlation of percentage agreement between instrument and “gold standard” (4×) Magnitude of the coefficients is hypothesis dependent (1×) | Range (for correlations, kappa, or ES/SRM, e.g., “0.00–0.39 low; 0.40–0.59 moderate; 0.60–0.79 moderately high; 0.80–1.0 high,” or “high ≥ 90%, κ > 0.60, r > 0.75; moderate ≥ 70%, κ ≥ 0.40, r ≥ 0.50; low < 70%, κ < 0.40, r < 0.50” (5×) Significant correlations (1×) Rating system not specified (2×) |
Responsiveness
| |
Standards (17×) | Criteria of adequacy (26×) |
“Adequate measure” used, e.g., ES, SRM (7×) Confirming hypotheses (6×) Calculating change scores (3×) Other measures, e.g., ROC curves (1×), Guyatt index of responsiveness (1×), relative efficacy (1×), Student’s t-test/Wilcoxon’s test (1×) Rating system not specified (5×) | Range or cut-off point for ES or SRM (11×) Hypotheses testing (5×) Significant difference (2×) ROC curve (1×) Intervention of known efficacy (1×) Rating system not specified (9×) |
Interpretability
| |
Standards and/or criteria of adequacy (7×) | |
Presenting MIC/MCIC (4×) | |
Presenting mean and SDs (e.g., for different subgroups, or before and after treatment) (4×) | |
Rating system not specified (1×) |